Cantel Medical Corp. (NASDAQ: CMD) Stocks Generating Improved Relative Strength

Cantel Medical Corp. day trading at USD 41.11 per share, then rallying to 43.57 and closing at USD 42.92 per share. A net gain of 4.41% for the day. Long term pricing analysis shows the stock trading at 53.58% lower than it’s 52week high and -93.71% higher than the 52week low. The share volume traded for the day was 1,283K which was 1 times the 50 Day Average Volume.

Cantel Medical Corp. had a market cap of 1,808,711K as of 28th May 2020. The Earnings Per Share (EPS) for Q4 2019 is $ 0.50.

Cantel Medical Corp. formerly Tweed Marijuana Inc., is a cannabis company based in Smiths Falls, Ontario. Tweed was founded by Bruce Linton and Chuck Rifici in 2013, and renamed Canopy Growth Corporation in 2015 after a merger with Bedrocan Canada.

Financial Results

Cantel Medical Corp. Second Quarter Of Fiscal 2020.

  • Net sales of $288.5M, up 28.5%, with organic sales growth of 1.3%
  • GAAP diluted EPS of $(0.05), down 111.1%
  • Non-GAAP diluted EPS of $0.61, up 7.0%
  • GAAP net loss of $2.3M, down 112.0%
  • Non-GAAP net income of $25.8M, up 9.5%

Cantel Medical Corp. (28th May 2020): The Institutional Ownership as of today stood at 103.66% and the Total Value of Holdings (millions) is $ 1,798.

New Institutional Holders and other activity – As of today, the total number of shares held is 43,682,148 by 276 institutional holders.

LATEST NEWS:

21-May-2020:- Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Third Quarter Ended April 30, 2020

CANTEL MEDICAL CORP. (NYSE: CMD) will release the results for its third quarter ended April 30, 2020, on Thursday, June 4, 2020, before the market opens, and hold a conference call to discuss the results at 8:30 a.m. ET.

13-May-2020:- Cancel Announces Pricing of $140 Million Private Offering of Convertible Senior Notes Due 2025

CANTEL MEDICAL CORP announced the pricing of its offering of $140 million aggregate principal amount of 3.25% convertible senior notes due 2025 (the “Notes”) in a private offering only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Company also granted the initial purchasers of the Notes an option to purchase, for settlement within a period of 13 days from, and including, the date on which the notes are first issued, up to an additional $28.0 million aggregate principal amount of Notes in the private placement. The issuance and sale of the Notes are scheduled to settle on or about May 15, 2020, subject to customary closing conditions.

Leave a Reply

Your email address will not be published. Required fields are marked *